Donanemab has been hailed as ‘game changer’ but the price tag has barred it from being available to nearly one million Brits.
This article, images and content belong to the source and curated for informational purposes.
Get the latest creative news from FooBar about art, design and business.
Donanemab has been hailed as ‘game changer’ but the price tag has barred it from being available to nearly one million Brits.
This article, images and content belong to the source and curated for informational purposes.